ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
17.18
-0.50 (-2.83%)
At close: Aug 1, 2025, 4:00 PM
17.17
-0.01 (-0.06%)
After-hours: Aug 1, 2025, 7:51 PM EDT
SpringWorks Therapeutics Market Cap
ARS Pharmaceuticals has a market cap or net worth of $1.69 billion as of August 1, 2025. Its market cap has increased by 53.70% in one year.
Market Cap
1.69B
Enterprise Value
1.48B
1-Year Change
53.70%
Ranking
Category
Stock Price
$17.18
Market Cap Chart
Since November 9, 2022, ARS Pharmaceuticals's market cap has increased from $568.25M to $1.69B, an increase of 196.93%. That is a compound annual growth rate of 49.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 1.69B | 64.57% |
| Dec 31, 2024 | 1.03B | 94.90% |
| Dec 29, 2023 | 526.06M | -34.23% |
| Dec 30, 2022 | 799.86M | 40.76% |
| Nov 9, 2022 | 568.25M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.37B |
| Johnson & Johnson | 402.99B |
| AbbVie | 344.84B |
| AstraZeneca | 228.08B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 221.54B |
| UnitedHealth Group | 215.69B |
| Novo Nordisk | 211.90B |